Search Results | Diabetes Care | American Diabetes Association

1-20 of 50

2 3

Sort by

Sort Order Select

Journal Articles

Changes in Circulating miR-375-3p and Improvements in Visceral and Hepatic Fat Contents in Response to Lifestyle Interventions: The CENTRAL Trial

Yoriko Heianza, Knut Krohn, Anat Yaskolka Meir, Xuan Wang, Stefanie Ziesche, Uta Ceglarek, Matthias Blüher, Maria Keller, Peter Kovacs, Iris Shai, Lu Qi

Diabetes Care 2022;45(8):1911–1913

DOI: https://doi.org/10.2337/dc21-2517

Published: 26 July 2022

View article

Journal Articles

Heterogeneity of Diabetes: β-Cells, Phenotypes, and Precision Medicine: Proceedings of an International Symposium of the Canadian Institutes of Health Research’s Institute of Nutrition, Metabolism and Diabetes and the U.S. National Institutes of Health’s National Institute of Diabetes and Digestive and Kidney Diseases

William T. Cefalu, Dana K. Andersen, Guillermo Arreaza-Rubín, Christopher L. Pin, Sheryl Sato, C. Bruce Verchere, Minna Woo, Norman D. Rosenblum

Diabetes Care 2022;45(1):3–22

DOI: https://doi.org/10.2337/dci21-0051

Published: 15 November 2021

View article

Journal Articles

Minimal Functional β-Cell Mass in Intraportal Implants That Reduces Glycemic Variability in Type 1 Diabetic Recipients

Pieter Gillard, MD, Robert Hilbrands, MD, Ursule Van de Velde, MSCN, Zhidong Ling, MD, Da Hae Lee, MD, Ilse Weets, MD, Frans Gorus, MD, Christophe De Block, MD, Leonard Kaufman, PHD, Chantal Mathieu, MD, Daniel Pipeleers, MD, Bart Keymeulen, MD

Diabetes Care 2013;36(11):3483–3488

DOI: https://doi.org/10.2337/dc13-0128

Published: 15 October 2013

View article

Includes: Supplementary data

Journal Articles

Ketosis-Prone Atypical Diabetes: Glucagon Is There, Too

Pierre Lefèbvre, MD ,PHD, FRCP, MAE

Diabetes Care 2013;36(1):8–10

DOI: https://doi.org/10.2337/dc12-1696

Published: 11 December 2012

View article

Journal Articles

Blood Glucose Control in Type 1 Diabetes With a Bihormonal Bionic Endocrine Pancreas

Steven J. Russell, MD, Firas H. El-Khatib, PHD, David M. Nathan, MD, Kendra L. Magyar, MSN, John Jiang, BS, Edward R. Damiano, PHD

Diabetes Care 2012;35(11):2148–2155

DOI: https://doi.org/10.2337/dc12-0071

Published: 13 October 2012

View article

Includes: Supplementary data

Journal Articles

Graves Hyperthyroidism After Stopping Immunosuppressive Therapy in Type 1 Diabetic Islet Cell Recipients With Pretransplant TPO Autoantibodies

Pieter Gillard, MD, PHD, Volkert Huurman, MD, PHD, Bart Van der Auwera, PHD, Brigitte Decallonne, MD, PHD, Kris Poppe, MD, PHD, Bart O. Roep, PHD, Frans Gorus, MD, PHD, Chantal Mathieu, MD, PHD, Daniel Pipeleers, MD, PHD, Bart Keymeulen, MD, PHD

Diabetes Care 2009;32(10):1817–1819

DOI: https://doi.org/10.2337/dc08-2339

Published: 23 June 2009

View article

Journal Articles

Retrospective Assessment of Islet Cell Autoantibodies in Pancreas Organ Donors

Stavros Diamantopoulos, MD, Gloria Allende, MS, Joseph M. Ferreira, Gaetano Ciancio, MD, George W. Burke, MD, Alberto Pugliese, MD

Diabetes Care 2008;31(9):1741–1742

DOI: https://doi.org/10.2337/dc08-0652

Published: 01 September 2008

View article

Journal Articles

Too Much Glucagon, Too Little Insulin: Time course of pancreatic islet dysfunction in new-onset type 1 diabetes

Rebecca J. Brown, MD, Ninet Sinaii, PHD, MPH, Kristina I. Rother, MD, MHSC

Diabetes Care 2008;31(7):1403–1404

DOI: https://doi.org/10.2337/dc08-0575

Published: 01 July 2008

View article

Journal Articles

Microencapsulated Pancreatic Islet Allografts Into Nonimmunosuppressed Patients With Type 1 Diabetes: First two cases

Riccardo Calafiore, MD, Giuseppe Basta, MD, Giovanni Luca, MD, Angelo Lemmi, MD, M. Pia Montanucci, PHD, Giuseppe Calabrese, MD, Leda Racanicchi, PHD, Francesca Mancuso, PHD, Paolo Brunetti, MD

Diabetes Care 2006;29(1):137–138

DOI: https://doi.org/10.2337/diacare.29.01.06.dc05-1270

Published: 01 January 2006

View article

Journal Articles

Hepatitis C Virus Infection and Human Pancreatic β-Cell Dysfunction

Matilde Masini, MD, Daniela Campani, MD, Ugo Boggi, MD, Michele Menicagli, MD, Nicola Funel, MD, Maria Pollera, MD, Roberto Lupi, PHD, Silvia Del Guerra, PHD, Marco Bugliani, PHD, Scilla Torri, PHD, Stefano Del Prato, MD, Franco Mosca, MD, Franco Filipponi, MD, Piero Marchetti, MD, PHD

Diabetes Care 2005;28(4):940–941

DOI: https://doi.org/10.2337/diacare.28.4.940

Published: 01 April 2005

View article

Journal Articles

Modulation of Oxidative and Antioxidative Status in Diabetes by Asphaltum Panjabinum

Nidhi Saxena, PHD, Upendra N. Dwivedi, PHD, Raj K. Singh, PHD, Arvind Kumar, MD, Chhavi Saxena, MSC, BAMS, Ram C. Saxena, MD, Mona Saxena, PHD

Diabetes Care 2003;26(8):2469–2470

DOI: https://doi.org/10.2337/diacare.26.8.2469-a

Published: 01 August 2003

View article

Journal Articles

Autoantibodies to a 38-kDa Glycosylated Islet Cell Membrane–Associated Antigen in (Pre)type 1 Diabetes: Association with IA-2 and islet cell autoantibodies

Frederic Winnock, PHARM, Michael R. Christie, PHD, Manou R. Batstra, PHD, Henk-Jan Aanstoot, MD, PHD, Ilse Weets, MD, Katelijn Decochez, MD, Philippe Jopart, MD, Dany Nicolaij, MD, Frans K. Gorus, MD, PHD, The Belgian Diabetes Registry

Diabetes Care 2001;24(7):1181–1186

DOI: https://doi.org/10.2337/diacare.24.7.1181

Published: 01 July 2001

View article

Journal Articles

Family Characteristics and Life Events Before the Onset of Autoimmune Type 1 Diabetes in Young Adults: A nationwide study

Bengt Littorin, MD, Göran Sundkvist, MD, PHD, Lennarth Nyström, BA, PHD, Anita Carlson, PHD, Mona Landin-Olsson, MD, PHD, Jan Östman, MD, PHD, Hans J. Arnqvist, MD, PHD, Elisabeth Björk, MD, PHD, Göran Blohmé, MD, PHD, Jan Bolinder, MD, PHD, Jan W. Eriksson, MD, PHD, Bengt Scherstén, MD, PHD, Lars Wibell, MD, PHD

Diabetes Care 2001;24(6):1033–1037

DOI: https://doi.org/10.2337/diacare.24.6.1033

Published: 01 June 2001

View article

Meeting Abstracts

Autoimmunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infection.

C Betterle, P Fabris, R Zanchetta, B Pedini, G Tositti, E Bosi, F de Lalla

Diabetes Care 2000;23(8):1177–1181

DOI: https://doi.org/10.2337/diacare.23.8.1177

Published: 01 August 2000

View article

Meeting Abstracts

Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset. Belgian Diabetes Registry.

K Decochez, B Keymeulen, G Somers, H Dorchy, I H De Leeuw, C Mathieu, R Rottiers, F Winnock, K ver Elst, I Weets, L Kaufman, D G Pipeleers, R Rottiers, Belgian Diabetes Registry

Diabetes Care 2000;23(8):1072–1078

DOI: https://doi.org/10.2337/diacare.23.8.1072

Published: 01 August 2000

View article

Meeting Abstracts

Function of pancreatic islets isolated from a type 1 diabetic patient.

P Marchetti, F Dotta, Z Ling, R Lupi, S Del Guerra, C Santangelo, M Realacci, L Marselli, U Di Mario, R Navalesi

Diabetes Care 2000;23(5):701–703

DOI: https://doi.org/10.2337/diacare.23.5.701

Published: 01 May 2000

View article

Meeting Abstracts

Enterovirus antibodies in relation to islet cell antibodies in two populations with high and low incidence of type 1 diabetes.

M Lönnrot, M Knip, D Marciulionyte, J Rahko, B Urbonaite, W P Moore, P Vilja, H Hyöty

Diabetes Care 1999;22(12):2086–2088

DOI: https://doi.org/10.2337/diacare.22.12.2086

Published: 01 December 1999

View article

Meeting Abstracts

Long-term prognosis of islet cell antibody-negative ketosis-onset diabetes with subsequent non-insulin dependency.

M Katakura, T Aizawa, M Naka, Y Funase, M Komatsu, K Yamauchi, K Yoshizawa, K Hashizume

Diabetes Care 1999;22(9):1584–1586

DOI: https://doi.org/10.2337/diacare.22.9.1584a

Published: 01 September 1999

View article

Meeting Abstracts

Islet cell and glutamic acid decarboxylase antibodies present at diagnosis of diabetes predict the need for insulin treatment. A cohort study in young adults whose disease was initially labeled as type 2 or unclassifiable diabetes.

B Littorin, G Sundkvist, W Hagopian, M Landin-Olsson, A Lernmark, J Ostman, H J Arnqvist, G Blohmé, J Bolinder, J W Eriksson, F Lithner, B Scherstén, L Wibell

Diabetes Care 1999;22(3):409–412

DOI: https://doi.org/10.2337/diacare.22.3.409

Published: 01 March 1999

View article

Meeting Abstracts

Clinical, immunological, and genetic heterogeneity of diabetes in an Italian population-based cohort of lean newly diagnosed patients aged 30-54 years. Piedmont Study Group for Diabetes Epidemiology.

G Bruno, A De Salvia, R Arcari, M Borra, N Grosso, Q Carta, M Trovati, M Veglio, G Pagano

Diabetes Care 1999;22(1):50–55

DOI: https://doi.org/10.2337/diacare.22.1.50

Published: 01 January 1999

View article

2 3

NARROW

Changes in Circulating miR-375-3p and Improvements in Visceral and Hepatic Fat Contents in Response to Lifestyle Interventions: The CENTRAL Trial

Minimal Functional β-Cell Mass in Intraportal Implants That Reduces Glycemic Variability in Type 1 Diabetic Recipients

Ketosis-Prone Atypical Diabetes: Glucagon Is There, Too

Blood Glucose Control in Type 1 Diabetes With a Bihormonal Bionic Endocrine Pancreas

Graves Hyperthyroidism After Stopping Immunosuppressive Therapy in Type 1 Diabetic Islet Cell Recipients With Pretransplant TPO Autoantibodies

Retrospective Assessment of Islet Cell Autoantibodies in Pancreas Organ Donors

Too Much Glucagon, Too Little Insulin: Time course of pancreatic islet dysfunction in new-onset type 1 diabetes

Microencapsulated Pancreatic Islet Allografts Into Nonimmunosuppressed Patients With Type 1 Diabetes: First two cases

Hepatitis C Virus Infection and Human Pancreatic β-Cell Dysfunction

Modulation of Oxidative and Antioxidative Status in Diabetes by Asphaltum Panjabinum

Autoantibodies to a 38-kDa Glycosylated Islet Cell Membrane–Associated Antigen in (Pre)type 1 Diabetes: Association with IA-2 and islet cell autoantibodies

Family Characteristics and Life Events Before the Onset of Autoimmune Type 1 Diabetes in Young Adults: A nationwide study

Autoimmunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infection.

Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset. Belgian Diabetes Registry.

Function of pancreatic islets isolated from a type 1 diabetic patient.

Enterovirus antibodies in relation to islet cell antibodies in two populations with high and low incidence of type 1 diabetes.

Long-term prognosis of islet cell antibody-negative ketosis-onset diabetes with subsequent non-insulin dependency.

Islet cell and glutamic acid decarboxylase antibodies present at diagnosis of diabetes predict the need for insulin treatment. A cohort study in young adults whose disease was initially labeled as type 2 or unclassifiable diabetes.

Clinical, immunological, and genetic heterogeneity of diabetes in an Italian population-based cohort of lean newly diagnosed patients aged 30-54 years. Piedmont Study Group for Diabetes Epidemiology.

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only